Primary Site >> Stomach Cancer
Gene >> FLT1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. PMID: 9816116 |
Ref: Genetic Alterations in Gastric Carcinomas and Adjacent Mucosa Detected by Comparative Genomic Hybridization (CGH). PMID: 26680801 |
Ref: Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells. PMID: 12439912 |
Ref: [Expression of MMP-9 and MMP-9 mRNA in gastric carcinoma and its correlation with angiogenesis]. PMID: 12899759 |
Ref: Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer. PMID: 15150121 Ref: Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library. PMID: 15197767 Ref: (64)Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-quantum dot-vascular endothelial growth factor PMID: 20641777 |
Ref: Effect of Weikangning on gastric cancer cell growth and expression of vascular endothelial growth factor and its receptors KDR and Flt-1. PMID: 15742392 Ref: Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. PMID: 16317086 |
Ref: A phase II study of infusional 5-fluorouracil and low-dose leucovorin with docetaxel for advanced gastric cancer. PMID: 16446551 Ref: H pylori status and angiogenesis factors in human gastric carcinoma. PMID: 17006982 Ref: [Effects of weikangning contained serum on growth of gastric cancer cell, expression of vascular endothelial growth factor and its receptors including KDR and fit-1]. PMID: 17569358 |
Ref: [Relationship between the expression of vascular endothelial growth factor, fms-like tyrosine kinase-1 and biological behavior in gastric carcinoma]. PMID: 17633783 Ref: Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice. PMID: 18161919 |
Ref: A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer. PMID: 18026677 Ref: Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma. PMID: 18609713 |
Ref: Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer. PMID: 19068081 Ref: The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation. PMID: 19633424 Ref: The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation. PMID: 28001118 |
Ref: Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG. PMID: 20434464 Ref: [Impact of HER2, EGFR, IGF-1R, and VEGFR expressions on the outcome of chemotherapy for advanced gastric cancer]. PMID: 20716873 Ref: [Tracers in oncology - preclinical and clinical evaluation]. PMID: 21152689 |
Ref: The function and mechanism of COX-2 in angiogenesis of gastric cancer cells. PMID: 21266034 Ref: A randomized trial of somatostatin to regulate the VEGFs/VEGFRs in patients with gastric cancer. PMID: 21937420 |
Ref: Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial. PMID: 22565005 Ref: Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. PMID: 22808003 Ref: Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer. PMID: 22842485 |
Ref: 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging. PMID: 23604223 Ref: Evaluation of FLT-PET/CT usefulness in diagnosis and qualification for surgical treatment of gastric cancer. PMID: 23788985 Ref: Evidence for angiogenesis-independent contribution of VEGFR1 (FLT1) in gastric cancer recurrence. PMID: 23801279 Ref: Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. PMID: 24090479 Ref: (18)F-FLT PET/CT in Patients with Gastric Carcinoma. PMID: 24454342 |
Ref: Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer. PMID: 24398900 Ref: Disseminated tumor cells in bone marrow of gastric cancer patients: correlation with tumor hypoxia and clinical relevance. PMID: 24669218 |
Ref: Delineation of gastric cancer subtypes by co-regulated expression of receptor tyrosine kinases and chemosensitivity genes. PMID: 26396673 Ref: Radiolabeling and evaluation of (64)Cu-DOTA-F56 peptide targeting vascular endothelial growth factor receptor 1 in the molecular imaging of gastric cancer. PMID: 26807312 |
Ref: Comparison of FLT-PET/CT and CECT in gastric cancer diagnosis. PMID: 26826089 Ref: Interleukin-8: A potent promoter of angiogenesis in gastric cancer. PMID: 26893688 Ref: Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab. PMID: 27623234 Ref: Evaluation of (18)F-fluorothymidine positron emission tomography ([(18)F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer. PMID: 27854031 Ref: Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers. PMID: 28078044 |
Ref: (125)I-F56 Peptide as Radioanalysis Agent Targeting VEGFR1 in Mice Xenografted with Human Gastric Tumor. PMID: 28197324 Ref: Multiple therapeutic peptide vaccines for patients with advanced gastric cancer. PMID: 28393243 Ref: Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1alpha and VEGF receptors. PMID: 28594907 |
Ref: Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased in vivo anti-tumor efficacy. PMID: 29721065 Ref: Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer. PMID: 29767252 Ref: Imaging peritoneal metastasis of gastric cancer with (18)F-fluorothymidine positron emission tomography/computed tomography: a proof-of-concept study. PMID: 29916721 |